Micafungin Pharmacenter

Micafungin, the active ingredient in Micafungin Pharmacenter, is an echinocandin antifungal presented as an intravenous solution for intravenous use. It is employed to treat invasive candidiasis, esophageal candidiasis, and to prevent Candida infections in patients undergoing hematopoietic stem cell transplantation. GNH USA supplies Micafungin Pharmacenter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide. The company follows stringent quality standards and provides regulatory‑approved batches to meet the needs of clinical and procurement teams across multiple regions.

Micafungin is used to treat fungal infections by targeting Candida species in several clinical scenarios. - Invasive candidiasis: provides effective therapy for bloodstream, intra‑abdominal and other deep‑tissue Candida infections, reducing mortality in immunocompromised patients. - Esophageal candidiasis: resolves infection of the esophageal mucosa caused by Candida species, improving dysphagia and pain. - Prophylaxis in hematopoietic stem cell transplantation: prevents Candida infection in transplant recipients during periods of neutropenia, supporting engraftment and reducing invasive disease. - Candidemia in neutropenic patients: treats documented bloodstream Candida infection in patients with prolonged neutropenia, offering rapid fungal clearance.

Micafungin may be associated with a range of adverse reactions, varying from mild to severe. Common Side Effects: - Fever - Headache - Nausea - Elevated liver enzymes (ALT/AST) Serious or Rare Side Effects: - Severe hepatic dysfunction - Anaphylactic reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis

When prescribing Micafungin, clinicians should consider several safety aspects. - Renal impairment: monitor kidney function and adjust therapy if needed. - Hepatic dysfunction: assess liver enzymes before and during treatment. - Concomitant antifungal therapy: avoid overlapping use with other echinocandins. - Pregnancy and lactation: use only if benefit outweighs risk; data are limited. - Infusion reactions: monitor for signs of hypersensitivity during administration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with other medicines, requiring careful management. Major Interactions (Avoid): - Co‑administration with strong cytochrome P450 inducers (e.g., rifampin) may reduce micafungin exposure. - Concurrent use with other echinocandins (e.g., caspofungin) increases risk of toxicity. Moderate Interactions (Monitor Closely): - Combination with azoles (e.g., fluconazole) may affect plasma levels. - Use with immunosuppressants (e.g., tacrolimus) warrants liver function monitoring. - Concomitant nephrotoxic agents (e.g., aminoglycosides) require renal function assessment.